Skip to main content
Log in

Fibrinogen/albumin ratio and carotid artery plaques in coronary heart disease patients with different glucose metabolic states: a RCSCD-TCM study

  • Original Article
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Aim

The relationship between fibrinogen/albumin ratio (FAR) and carotid artery plaques (CAPs) was investigated in patients with coronary heart disease (CHD).

Methods

A total of 11,624 patients with CHD were enrolled and divided into quartiles based on the FAR (Q1: FAR index ≤ 0.0663; Q2: 0.0664 ≤ FAR index ≤ 0.0790; Q3: 0.0791 ≤ FAR index ≤ 0.0944; Q4: FAR index > 0.0944). Patients were classified into three groups according to their blood glucose levels: normal glucose regulation (NGR), prediabetes mellitus (pre-DM), and diabetes mellitus (DM) groups. Carotid ultrasonography was performed to detect CAPs. The relationship between FAR and CAPs was evaluated using logistic and subgroup analyses.

Results

Among 11,624 participants, 8738 (75.14%) had CAPs. Compared with Q1, the odds ratio (OR) of Q4 in patients with CHD was 2.00 (95% confidence interval [CI]: 1.71–2.34) after multivariate adjustment. Taking Q1 as a reference, a higher OR was observed in Q4 of FAR for CAPs in men [OR: 2.26; 95% CI: 1.73–2.95] in the multi-adjusted models. Moreover, multivariate adjustment indicated that the highest OR was observed in patients with CHD and DM (OR: 2.36; 95% CI: 1.80–3.10).

Conclusions

A significant association between FAR and CAPs was observed in patients with CHD, regardless of sex or blood glucose levels. Therefore, FAR may be used as an effective indicator to identify patients at a high risk of CAPs among patients with CHD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Abbreviations

FAR:

Fibrinogen/albumin ratio

CHD:

Coronary heart disease

CAPs:

Carotid artery plaques

NLR:

Neutrophil/lymphocyte ratio

PLR:

Platelet/lymphocyte ratio

LMR:

Lymphocyte/monocyte ratio

BMI:

Body mass index

DM:

Diabetes mellitus

HbA1c:

Glycated hemoglobin

FIB:

Fibrinogen

ALB:

Albumin

FPG:

Fasting plasma glucose

LDL-C:

Low-density lipoprotein cholesterol

TG:

Triglycerides

HDL-C:

High-density lipoprotein cholesterol

TC:

Total cholesterol

NGR:

Normal glucose regulation

Pre-DM:

prediabetes mellitus

SBP:

Systolic blood pressure

DBP:

Diastolic blood pressure

IMT:

Intima-media thickness

OR:

Odds ratio

CI:

Confidence interval

IQR:

Interquartile range

MACE:

Major adverse cardiovascular events

References

  1. P. Libby, Inflammation in atherosclerosis—no longer a theory. Clin. Chem. 67(1), 131–142 (2021). https://doi.org/10.1093/clinchem/hvaa275

    Article  PubMed  Google Scholar 

  2. O.P. Akinyelure, L.D. Colantonio, N.S. Chaudhary et al. Inflammation biomarkers and incident coronary heart disease: the reasons for geographic and racial differences in stroke study. Am. Heart J. 253(undefined), 39–47 (2022). https://doi.org/10.1016/j.ahj.2022.07.001

    Article  CAS  PubMed  Google Scholar 

  3. Y. Liu, Z. Li, X. Wang et al. Effects of adjuvant Chinese patent medicine therapy on major adverse cardiovascular events in patients with coronary heart disease angina pectoris: a population-based retrospective cohort study. Acupunct. Herb. Med 2(2), 110–118 (2022). https://doi.org/10.1097/HM9.0000000000000028

    Article  Google Scholar 

  4. N. Puig, P. Camps-Renom, M. Camacho et al. Plasma sICAM-1 as a biomarker of carotid plaque inflammation in patients with a recent ischemic stroke. Translational Stroke Research, 1–12 (2022). https://doi.org/10.1007/s12975-022-01002-x

  5. W.B. Horton, E.J. Barrett, Microvascular dysfunction in diabetes mellitus and cardiometabolic disease. Endocr. Rev. 42(Jan 1), 29–55 (2021). https://doi.org/10.1210/endrev/bnaa025

    Article  PubMed  Google Scholar 

  6. X. Cheng, Z. Li, M. Yang, Y. Liu, S. Wang et al. Association of HbA1c with carotid artery plaques in patients with coronary heart disease: a retrospective clinical study. Acta Cardiologica, 1–9 (2022). https://doi.org/10.1080/00015385.2022.2040822

  7. C. Chen, C. Lu, W. Liu et al. Association between fibrinogen/albumin ratio and arterial stiffness in patients with type 2 diabetes: a cross-sectional study. Front. Pharmacol. 13, 1120043 (2023). https://doi.org/10.3389/fphar.2022.1120043

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. L. Fu, Z. Liu, Y. Liu, Fibrinogen-like protein 2 in inflammatory diseases: a future therapeutic target. Int. Immunopharmacol. 116, 109799 (2023). https://doi.org/10.1016/j.intimp.2023.109799

    Article  CAS  PubMed  Google Scholar 

  9. C.T. Hsieh, K.L. Chien, H.C. Hsu et al. Associations between fibrinogen levels and the risk of cardiovascular disease and all-cause death: a cohort study from the Chin-Shan community in Taiwan. BMJ Open 12(4), e054638 (2022). https://doi.org/10.1136/bmjopen-2021-054638

    Article  PubMed  PubMed Central  Google Scholar 

  10. D. Yuan, P. Jiang, P. Zhu et al. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study. Cardiovasc. Diabetol. 20(1), 1–13 (2021). https://doi.org/10.1186/s12933-021-01335-1

    Article  CAS  Google Scholar 

  11. G.J. Quinlan, G.S. Martin, T.W. Evans, Albumin: biochemical properties and therapeutic potential. Hepatology 41(6), 1211–1219 (2005). https://doi.org/10.1002/hep.20720

    Article  CAS  PubMed  Google Scholar 

  12. Y.Y. Zheng, T.T. Wu, Y. Chen et al. Gamma‐glutamyl transferase to albumin ratio as a novel predictor of bleeding events and mortality in patients after percutaneous coronary intervention: a retrospective cohort study. Catheter. Cardiovasc. Interven. 95, 572–578 (2020). https://doi.org/10.1002/ccd.28696

    Article  Google Scholar 

  13. Z. Duan, C. Luo, B. Fu et al. Association between fibrinogen-to-albumin ratio and the presence and severity of coronary artery disease in patients with acute coronary syndrome. BMC Cardiovasc. Disord. 21(1), 1–10 (2021). https://doi.org/10.1186/s12872-021-02400-z

    Article  CAS  Google Scholar 

  14. M. Li, C. Tang, E. Luo et al. Relation of fibrinogen-to-albumin ratio to severity of coronary artery disease and long-term prognosis in patients with non-ST elevation acute coronary syndrome. BioMed Res. Int. 2020 (2020). https://doi.org/10.1155/2020/1860268

  15. B. Deveci, E. Gazi, Relation between globulin, fibrinogen, and albumin with the presence and severity of coronary artery disease. Angiology 72(2), 174–180 (2021). https://doi.org/10.1177/0003319720959985

    Article  CAS  PubMed  Google Scholar 

  16. P. Wang, D. Yuan, C. Zhang et al. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort. Cardiovasc. Diabetol. 21(1), 1–13 (2022). https://doi.org/10.1186/s12933-022-01477-w

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. T. Corriere, S. Di Marca, E. Cataudella et al. Neutrophil-to-Lymphocyte ratio is a strong predictor of atherosclerotic carotid plaques in older adults. Nutr. Metab. Cardiovasc. Dis. 28(1), 23–27 (2018). https://doi.org/10.1016/j.numecd.2017.10.022

    Article  CAS  PubMed  Google Scholar 

  18. X. Li, J. Li, G. Wu, Relationship of neutrophil-to-lymphocyte ratio with carotid plaque vulnerability and occurrence of vulnerable carotid plaque in patients with acute ischemic stroke. BioMed Res. Int. 2021 (2021). https://doi.org/10.1155/2021/6894623

  19. C. Varım, P. Varım, B.A. Acar et al. Usefulness of the platelet-to-lymphocyte ratio in predicting the severity of carotid artery stenosis in patients undergoing carotid angiography. Kaohsiung J. Med. Sci. 32(2), 86–90 (2016). https://doi.org/10.1016/j.kjms.2015.12.007

    Article  PubMed  Google Scholar 

  20. A. Bolayir, E. Bolayir, Can lymphocyte to monocyte ratio be used as a predictor of atherosclerotic carotid plaques in elderly adults? Cumhur. Med. J. 40(2), 120–127 (2018). https://doi.org/10.7197/223.v40i37154.406575

    Article  CAS  Google Scholar 

  21. Y. Liu, M. Ma, L. Li et al. Association between sensitivity to thyroid hormones and dyslipidemia in patients with coronary heart disease. Endocrine 79(3), 459–468 (2023). https://doi.org/10.1007/s12020-022-03254-x

    Article  CAS  PubMed  Google Scholar 

  22. S.Y. Kim, The definition of obesity[J]. Korean J. Fam. Med. 37(6), 309–309 (2016). https://doi.org/10.4082/kjfm.2016.37.6.309

    Article  PubMed  PubMed Central  Google Scholar 

  23. American Diabetes Association, Standards of medical care in diabetes–2013. Diabetes Care 36(Suppl 1), S11–S66 (2013). https://doi.org/10.2337/dc13-s011

    Article  Google Scholar 

  24. F. Mach, C. Baigent, A.L. Catapano et al. ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis 290, 140–205 (2020). https://doi.org/10.1016/j.atherosclerosis.2019.08.014

    Article  CAS  Google Scholar 

  25. B. Williams, G. Mancia, W. Spiering et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). Eur. Heart J. 39(33), 3021–3104 (2018). https://doi.org/10.1714/3026.30245

    Article  PubMed  Google Scholar 

  26. J.H. Stein, C.E. Korcarz, R.T. Hurst et al. American Society of Echocardiography Carotid intima-media thickness task force. Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: a consensus statement from the American Society of Echocardiography Carotid intima-media thickness task force. Endorsed by the society for vascular medicine. J. Am. Soc. Echocardiogr. 21(2), 93–111 (2008). https://doi.org/10.1016/j.echo.2007.11.011

    Article  PubMed  Google Scholar 

  27. Z. Li, Y. He, S. Wang et al. Association between triglyceride glucose index and carotid artery plaque in different glucose metabolic states in patients with coronary heart disease: a RCSCD-TCM study in China. Cardiovasc. Diabetol. 21(1), 1–11 (2022). https://doi.org/10.1186/s12933-022-01470-3

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. W. Zhang, L. Liu, H. Chen et al. Association between the triglyceride-glucose index and the presence and prognosis of coronary microvascular dysfunction in patients with chronic coronary syndrome. Cardiovasc. Diabetol. 22(1), 1–13 (2023). https://doi.org/10.1186/s12933-023-01846-z

    Article  CAS  Google Scholar 

  29. L. Song, X. Zhao, R. Chen et al. Association of PCSK9 with inflammation and platelet activation markers and recurrent cardiovascular risks in STEMI patients undergoing primary PCI with or without diabetes. Cardiovasc. Diabetol. 21(1), 1–13 (2022). https://doi.org/10.1186/s12933-022-01519-3

    Article  CAS  Google Scholar 

  30. L. Gago, M. del Mar Vila, M. Grau et al. An end-to-end framework for intima media measurement and atherosclerotic plaque detection in the carotid artery. Comput. Methods Prog. Biomed. 223, 106954 (2022). https://doi.org/10.1016/j.cmpb.2022.106954

    Article  Google Scholar 

  31. L. Fang, F.H. Yan, C. Liu et al. Systemic inflammatory biomarkers, especially fibrinogen to albumin ratio, predict prognosis in patients with pancreatic cancer. Cancer Res. Treat.: Off. J. Korean Cancer Assoc. 53(1), 131–139 (2021). https://doi.org/10.4143/crt.2020.33

    Article  CAS  Google Scholar 

  32. B. Li, H. Deng, B. Lei et al. The prognostic value of fibrinogen to albumin ratio in malignant tumor patients: a meta-analysis. Front. Oncol. 12. (2022). https://doi.org/10.3389/fonc.2022.985377

  33. L. Xiao, Y. Jia, X. Wang et al. The impact of preoperative fibrinogen-albumin ratio on mortality in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Clin. Chim. Acta 493, 8–13 (2019). https://doi.org/10.1016/j.cca.2019.02.018

    Article  CAS  PubMed  Google Scholar 

  34. J.J. Man, J.A. Beckman, I.Z. Jaffe, Sex as a biological variable in atherosclerosis. Circ. Res. 126(9), 1297–1319 (2020). https://doi.org/10.1161/circresaha.120.315930

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. D.H.K. van Dam-Nolen, N.C.M. van Egmond, K. Dilba et al. Sex differences in plaque composition and morphology among symptomatic patients with mild-to-moderate carotid artery stenosis. Stroke 53(2), 370–378 (2022). https://doi.org/10.1161/strokeaha.121.036564

    Article  PubMed  PubMed Central  Google Scholar 

  36. D.H.K. van Dam-Nolen, N.C.M. van Egmond, P.J. Koudstaal et al. Sex differences in carotid atherosclerosis: a systematic review and meta-analysis. Stroke 54(2), 315–326 (2023). https://doi.org/10.1161/strokeaha.122.041046

    Article  PubMed  Google Scholar 

  37. R. Huang, Q. Dai, L. Chang et al. The association between fibrinogen-to-albumin ratio (FAR) and adverse prognosis in patients with acute decompensated heart failure at different glucose metabolic states. Cardiovasc. Diabetol. 21(1), 1–13 (2022). https://doi.org/10.1186/s12933-022-01662-x

    Article  CAS  Google Scholar 

  38. S.T. Smiley, J.A. King, W.W. Hancock, Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J. Immunol. 167(5), 2887–2894 (2001). https://doi.org/10.4049/jimmunol.167.5.2887

    Article  CAS  PubMed  Google Scholar 

  39. C.M. Shannon, S.H. Ballew, N. Daya et al. Serum albumin and risks of hospitalization and death: findings from the atherosclerosis risk in communities study. J. Am. Geriatrics Soc. 69(10), 2865–2876 (2021). https://doi.org/10.1111/jgs.17313

    Article  Google Scholar 

  40. E. Hasheminasabgorji, J.C. Jha, Dyslipidemia, diabetes and atherosclerosis: role of inflammation and ROS-redox-sensitive factors. Biomedicines 9(11), 1602 (2021). https://doi.org/10.3390/biomedicines9111602

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. U.P. Gujral, R. Jagannathan, S. He et al. Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis. BMJ Open Diabetes Res. Care 9(1), e001776 (2021). https://doi.org/10.1136/bmjdrc-2020-001776

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank all those who participated in the study, the research teams, and the support groups.

Funding

This work was supported by A Cohort Study on Xuefu Zhuyu Cangina pectorissule in the Adjuvant Treatment of Coronary Heart Disease and Angina Pectoris (HX2020-16), the National Natural Science Foundation of China (82074140), the National Natural Science Foundation of China (82104565), and the National Natural Science Foundation of China (82204142).

Author information

Authors and Affiliations

Authors

Contributions

X.W., C.Y., and Z.L. participated in the research design and statistical analysis. M.H., M.M., and L.L. compiled the data. R.Y., S.G., Y.H., and Y.L. collected the data. All the authors have read and approved the final manuscript.

Corresponding authors

Correspondence to Lin Li, Shan Gao or Chunquan Yu.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, X., Huang, M., Li, Z. et al. Fibrinogen/albumin ratio and carotid artery plaques in coronary heart disease patients with different glucose metabolic states: a RCSCD-TCM study. Endocrine 84, 100–108 (2024). https://doi.org/10.1007/s12020-023-03558-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-023-03558-6

Keywords

Navigation